{
  "schemaVersion": 1,
  "id": "research-067",
  "slug": "067-from-a-growth-hormone-signal-to-an-outcome-in-people",
  "title": "From a growth hormone signal to an outcome in people",
  "catalogLabel": "CJC-1295 No DAC",
  "productCollection": "https://heritagebiolabs.com/research-library/products/cjc-1295-no-dac",
  "productHandles": [
    "cjc-1295-no-dac-623",
    "cjc-1295-no-dac-520",
    "cjc-1295-no-dac-609"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/cjc-1295-no-dac-623",
    "https://heritagebiolabs.com/product/cjc-1295-no-dac-520",
    "https://heritagebiolabs.com/product/cjc-1295-no-dac-609"
  ],
  "readingFocus": "Mechanisms & biology",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 269,
  "sourceYears": [
    2024
  ],
  "paragraphs": [
    "Short chains of amino acids linked by peptide bonds can work as messages from one tissue to another. CJC-1295 No DAC generally refers to Mod GRF (1–29), a 29-residue analogue designed around the natural signal for growth hormone release. An important research question is how a hormone measurement could be connected to an outcome that matters to people with growth hormone deficiency. [1]",
    "That connection has several steps. First comes the question of whether the precise compound activates the receptor in a controlled experiment. Then researchers can ask whether it changes blood growth hormone concentrations and, over time, changes insulin-like growth factor 1 (IGF-1). IGF-1 is one of the body's downstream responses to growth hormone. Even if those measurements move as expected, a trial designed to evaluate treatment would still need to assess outcomes in people with the condition. [1]",
    "When the FDA evaluated growth hormone deficiency as a proposed use in 2024, it found no clinical effectiveness studies in people with that condition for the CJC-1295 forms it assessed. It also found no human studies of the specific no-DAC free base or its acetate salt. The published human studies it could identify used the DAC active molecule and focused on healthy adults. [1]",
    "No recent primary study was identified here that closes the gap for the no-DAC form. The older regulatory briefing distinguishes the proposed indication from the evidence actually available. A clinical study would need to define who has the condition, choose a relevant comparison group and follow a suitable outcome over time. Short-term changes in a laboratory result would provide one part of that evidence. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "U.S. Food and Drug Administration. December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting. FDA briefing document on CJC-1295-related bulk drug substances (publication 2024-12-04).",
      "url": "https://www.fda.gov/media/183819/download"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/067-from-a-growth-hormone-signal-to-an-outcome-in-people",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/067-from-a-growth-hormone-signal-to-an-outcome-in-people.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/067-from-a-growth-hormone-signal-to-an-outcome-in-people.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 014 - CJC-1295 No DAC and CJC-1295 With DAC.docx",
    "sourceArticleNumber": 67,
    "contentSha256": "22238ea65afa8da3a40d15523a828831cfeab67650c133e2a49e87101fbaf7e5",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
